Virginia Retirement Systems’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Virginia Retirement Systems’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-17,000	Closed	-$174K	–	1063
2016 Q3	$174K	Sell	17,000 -7,200	-30%	-$78.4K	﹤0.01%	898
2016 Q2	$316K	Buy	+24,200	New	+$317K	﹤0.01%	818
2015 Q4	$224K	Sell	24,300 -400	-2%	-$3.35K	﹤0.01%	941
2015 Q3	$171K	Buy	24,700 +1,600	+7%	+$13.7K	﹤0.01%	959
2015 Q2	$227K	Sell	23,100 -1,400	-6%	-$12.8K	﹤0.01%	920
2015 Q1	$217K	Buy	+24,500	New	+$195K	﹤0.01%	931

Other funds holding SCLN

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Virginia Retirement Systems's SCLN Position: Q4 2016 in Review

Virginia Retirement Systems sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2016, closing a stake of 17,000 shares — an estimated $174K sold.

Virginia Retirement Systems first reported a position in SCLN in Q1 2015 and held it in 6 quarters. The position peaked at $316K in Q2 2016. 153 funds tracked by Wall St. Rank hold SCLN as of Q4 2016.

Virginia Retirement Systems reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
Virginia Retirement Systems sold 17,000 Sciclone Pharmaceuticals Inc shares in Q4 2016, an estimated $174K.
Virginia Retirement Systems first reported a position in Sciclone Pharmaceuticals Inc in Q1 2015 and held it in 6 quarters.
Virginia Retirement Systems's Sciclone Pharmaceuticals Inc position peaked at $316K in Q2 2016.
153 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2016.

Based on Virginia Retirement Systems's 13F filing for Q4 2016, filed 2 Feb 2017.